Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received October 8, 2013
- Revision received November 25, 2013
- Accepted November 27, 2013
- Published online January 8, 2014.
Copyright & Usage
Copyright© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
Author Information
- 1Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, U.S.A.
- 2Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, U.S.A.
- Correspondence to: Stephen J. Lippard, Department of Chemistry, Massachusetts Institute of Technology, 77 Massachusetts Av., Cambridge, MA, 02139, U.S.A. Tel: +1 6172531848, e-mail: lippard{at}mit.edu
Statistics from Altmetric.com
Cited By...
In this issue
Jump to section
Related Articles
Cited By...
- Applicability of Castration Model in Sex Difference Studies: Insights from Metabolome and Transcriptome Analyses
- Neural circuit mechanisms of sensorimotor disability in cancer treatment
- Thermodynamic genome-scale metabolic modeling of metallodrug resistance in colorectal cancer
- DNA damage repair as a target in pancreatic cancer: state-of-the-art and future perspectives
- Cancer Exacerbates Chemotherapy-Induced Sensory Neuropathy
- Cancer Exacerbates Chemotherapy Induced Sensory Neuropathy
- Structural basis for the bypass of the major oxaliplatin-DNA adducts by human DNA polymerase {eta}
- Chemotherapy Combines Effectively with Anti-PD-L1 Treatment and Can Augment Antitumor Responses
- 18F-Labeled Carboplatin Derivative for PET Imaging of Platinum Drug Distribution
- Exploring Intein Inhibition by Platinum Compounds as an Antimicrobial Strategy
- The state-of-play and future of platinum drugs
- Structural and mechanistic studies of polymerase {eta} bypass of phenanthriplatin DNA damage